Global Information
회사소개 | 문의 | 위시리스트

세계의 상용 바이오테크놀러지 분리 시스템 시장

Commercial Biotechnology Separation Systems

리서치사 Global Industry Analysts, Inc.
발행일 2019년 05월 상품 코드 352667
페이지 정보 영문 262 Pages
가격
US $ 5,600 ₩ 6,728,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,800 ₩ 20,185,000 PDF by E-mail (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 상용 바이오테크놀러지 분리 시스템 시장 Commercial Biotechnology Separation Systems
발행일 : 2019년 05월 페이지 정보 : 영문 262 Pages

세계의 상용 바이오테크놀러지 분리 시스템(Commercial Biotechnology Separation Systems) 시장에 대해 조사했으며, 시장 현황과 향후 성장 예측, 지역별 동향, 시장에 참여하는 기업 개요 등의 정보를 전해드립니다.

제1장 서론, 조사 방법, 정의

제2장 업계 개요

  • 분리 기술이 바이오테크놀러지 업계를 촉진
  • 선진국이 리드하지만 신흥국이 유망
  • DNA 마이크로어레이 : 최대이자 최고 속도의 성장 부문
  • 액체 크로마토그래피 : 주요 분리 기술 중 하나
  • 시장 성장을 지속시키는 요인
  • 성장을 저해하는 요인

제3장 시장 동향과 성장 촉진요인

제4장 분리 기술 : 시장 분석

  • 크로마토그래피 : 세계의 표준적 분리 및 정화 기술
  • 시장 전망
  • 효율성 개선이 친화성 크로마토그래피에서 합성 리간드의 사용을 촉진
  • 크로마토그래피의 프리팩 일회용 컬럼에 주목
  • SMBC 등

제5장 제품 개요

  • 개요
  • 유세포분석기(Flow Cytometry)
  • 크로마토그래피
  • 막분리
  • 바이오칩
  • 마이크로어레이
  • 원심분리
  • 전기영동

제6장 경쟁 상황

  • 주요 기업
  • 제품 출시/인가
  • 최근의 업계 활동

제7장 세계 시장 전망

제8장 지역별 시장 전망

  • 미국
  • 캐나다
  • 일본
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 라틴아메리카
  • 기타

제9장 기업 개요

KSM 18.10.25

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This report analyzes the worldwide markets for Commercial Biotechnology Separation Systems in US$ Million. The Global market is further analyzed by the following Types: DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 46 companies including many key and niche players such as -

3M
AB Sciex LLC
Agilent Technologies, Inc.
Alfa Laval AB
Alfa Wassermann Separation Technologies, LLC
Beckman Coulter, Inc.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

2. INDUSTRY OVERVIEW

  • Separation Technologies Drive Biotechnology Industry
  • Developed Markets Lead the Way while Emerging Markets Promise Growth
  • DNA Microarrays - Largest & Fastest Growing Segment
    • Table 1: Global Microarrays Market (2017): Percentage Share Breakdown of Sales for Academic/Government, Pharma, and Industrial Sectors (includes corresponding Graph/Chart)
  • Liquid Chromatography - One of the Leading Biotechnology Separation Technologies
  • Factors Sustaining Market Growth
  • Factors Restraining Growth

3. MARKET TRENDS & DRIVERS

  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Surging Biopharmaceutical Market Spurs Demand for Bioseparation Systems
    • Table 2: CDER NME NDAs/BLAs Filings and Approvals: As of November 30, 2017 (includes corresponding Graph/Chart)
  • New Biologic License Application (BLA) Approvals-2017
  • New Biologic License Application (BLA) Approvals: 2016
  • New Biologic License Application (BLA) Approval: 2015
  • Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
  • Increasing Emphasis on Personalized Medicine Drives Market Growth
  • Rise in Healthcare Spending Bodes Well for Market Growth
    • Table 3: Healthcare Spending as a Percentage of GDP by Region (2016) (includes corresponding Graph/Chart)
    • Table 4: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2016) (includes corresponding Graph/Chart)
  • Aging Population Drives Biotechnology Separation Systems Market
  • Global Aging Population Statistics - Opportunity Indicators
    • Table 5: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 6: Global Population Statistics for the 60+ Age Group by Region: 2017 (includes corresponding Graph/Chart)
    • Table 7: Global Population Statistics for the 65+ Age Group by Select Countries: 2016 (includes corresponding Graph/Chart)
    • Table 8: Global Life Expectancy at Birth (Years) by Geographic Region: 1950-2050 (includes corresponding Graph/Chart)
  • Increasing Incidence of Cancer Drives Biotechnology Separation Systems Market
    • Table 9: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 10: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
  • Increasing Competition Spurs Renewed Focus on Efficiencies
  • Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
  • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
  • Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
  • Protein Separation in Biopharmaceutical Space Assumes Greater Significance
  • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies: 2014-2017
  • An Insight into Bioseparation of mAbs
  • Market Potential for Biosimilars - A Case for Substantial Demand for Separation Technologies
    • Table 11: Global Biosimilars Market in US$ Million for 2015-2022 (includes corresponding Graph/Chart)
  • US Approved Biosimilars as of December 2017
  • Europe Approved Biosimilars as of December 2017
  • Patent Expiries Create Opportunities for Biosimilar Manufacturers
    • Patent Expiries of Major Biologics in the US and Europe
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
    • Table 12: Biopharmaceutical Products' Pipeline by Therapeutic Category: As of August 2016 (includes corresponding Graph/Chart)
    • Table 13: Biopharmaceutical Products' Pipeline by Clinical Phase: As of August 2016 (includes corresponding Graph/Chart)
    • Table 14: Biopharmaceutical Cancer Products Pipeline: As of August 2016 (includes corresponding Graph/Chart)
  • Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
  • Single-Use Products Gain Significant Attention
  • Market Prospects for Single-Use Disposable Technologies
    • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Modular Bioprocessing - An Emerging Trend
  • Leachables and Extractables Trounce Enthusiasm around Disposables

4. SEPARATION TECHNOLOGIES - MARKET ANALYSIS

  • Chromatography - The Gold Standard Separation and Purification Technology
    • Table 15: Global Chromatography Market (2017): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others (includes corresponding Graph/Chart)
  • Market Outlook
    • Ongoing Developments and Innovations Create Strong Demand for Columns
    • Table 16: Global High Performance Liquid Chromatography (HPLC) Market (2017): Percentage Share Breakdown of Sales by Industry for Academia, Agriculture, Chemical, Clinical, CROs, Government, Pharma & Biotech, and Others (includes corresponding Graph/Chart)
  • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
  • Pre-packed Disposable Columns in Chromatography Gain Attention
    • Clinical Trials - the Largest Market for Pre-packed Disposable Columns
  • SMBC - An Old Approach Gaining Significant Attention
  • Major Advantages and Disadvantages of SMBC
  • Twin-Column SMB - An Emerging Alternative to Protein A Columns
  • Growing Focus on Alternatives to Protein A Chromatography
    • Precipitation and Crystallization - Techniques with Major Use in Protein Purification
      • Reversible Precipitation - A Novel Bioseparation Technology
  • Alternatives to Protein A-based Chromatography to See Significant Adoption
  • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
  • Microarrays Witness Tremendous Growth
  • Protein Biochips - Set for Robust Expansion
  • Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
  • Current Approaches to Biochips
  • Advancements in Biochip Technology
  • Technological Differentiation in Demand
  • Biochip Technology Boosts Personalized Medicine
  • Biochip Technology Spreads beyond Pharma Industry
  • Data on Specificity of Effect Drives Use of Microarrays in Cosmetics and Personal Healthcare
    • Need for Alternative Techniques - The Key Drawback
  • Membrane Separation - A Promising Separation Technology
  • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
    • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
    • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
  • Membrane Filtration Gains Widespread Application in Food Industry
    • Membrane Separation in Dairy Industry
      • A Note on Applications of Select Other Membrane Technologies in Dairy Industry
      • Ultrafiltration - A Widely Used Technique for Mineral Separation from Milk Products
      • Polymeric Membrane-based Separations Gain Attention in Dairy Sector
      • Novel Techniques Emerge to Prevent Solubility of Milk Protein Concentrate
  • Flow Cytometry - A Key Laboratory Analytical Technology
  • Developing Countries Present Growth Opportunities
  • Cell-based Flow Cytometry Lead the Pack
  • Research & Clinical Laboratories - Largest End-Use Segments
    • A Gist of Major Growth Drivers
    • Growth Barriers/Key Challenges
  • Technological Advances Boost Cytometric System Sales
  • Novel Cytometers Advance Technological Evolution
  • Mass Cytometry - A New Technology in Flow Cytometry
  • Microfluidics Take Cell Sorting to a New Level
  • Flow Cytometer Faces Competition from Alternative Instruments
  • Increasing Role of Flow Cytometry in Disease Diagnosis
  • IVD Application Market Set to Rise
  • Large-Scale Screening Operations - Untapped Domain
  • Rising Use of Image Flow Cytometry in Clinical Applications
  • Rising HIV Prevalence Provides Growth Opportunities for POC Flow Cytometry
  • Centrifugation - A Key Separation Technology in Biopharmaceutical Production
  • Growing Proteomic Research Drives Demand for Electrophoresis Equipment
  • Major Application Areas of Electrophoresis Equipment
    • Table 17: Global Capillary Electrophoresis Equipment Market by Application Sector (2017): Percentage Share Breakdown of Value Sales for Pharmaceutical, Bioscience, Chemical, Food/Beverages and Other Application Sectors (includes corresponding Graph/Chart)
  • Capillary Electrophoresis Gains Prominence
  • 2D Gel Electrophoresis Market Gains Ground
    • Overview of the 2D Gel Electrophoresis Market
    • Advent of 2D-DIGE
    • Factors Driving Growth of Two-Dimensional Gel Electrophoresis Market
  • Reconfigured by Technology
  • Product Innovations Sustain Sales
  • Advanced Gel-Imaging Systems: An Emerging Market with Promising Growth
  • Magnetic Separations - An Overview

5. PRODUCT OVERVIEW

  • Biotechnology Separation Systems - An Overview
  • Flow Cytometry - An Introduction
    • Flow Cytometers
      • Fluidics System
      • Optical System
      • Electronics System
    • Application Areas - An Overview
      • Versatile Use
      • Clinical Applications
      • Research Applications
      • Drug Discovery
      • Biomedical Research
      • Fetal Cell Separation
      • Stem Cell Sorting
      • Marine Biology and Environmental Sciences
      • Microbiology
  • Chromatography: A Popular Separation Technology
    • Liquid Chromatography - An Overview
      • General Scheme
      • Column Chromatography
      • Chromatography Components
      • Mobile Phase
      • Stationary Phase
      • Advantages and Disadvantages of Different Types of Liquid Chromatography
  • Membrane Separation
  • Biochips - Complex Blend of Biochemistry and Electronics
    • Classification of Biochips
  • Microarrays
  • Centrifuges - A Technical Overview
    • Batch and Semi-Batch Centrifugation
    • Types of Preparative Centrifuges
      • Tubular Bowl Centrifuge
      • Disk Stack Centrifuge
      • Chamber Bowl
      • Ultracentrifuge
      • Decanter Centrifuge
      • Centrifugal Filter
  • Electrophoresis
    • Types of Electrophoresis
      • Conventional/Gel Electrophoresis
      • Slab Gel Electrophoresis
      • Polyacrylamide Gel Electrophoresis (PAGE)
      • Two-Dimensional Gel Electrophoresis
      • Capillary Electrophoresis
      • Advantages of Capillary Electrophoresis Instruments
      • Enables Sizing of a Piece of DNA Down to a Single Base
      • Exhibits High Resolution and Fluorescently Labels Multiplexed PCR Products
      • Allow Rapid Separations Due to Generation of High Voltages
      • Produces Reliable Analysis Results
      • Allows Residual Disease Testing of Engraftment Studies of Bone Marrow Transplant
      • Allows Testing for FLT3 Mutation
      • Separation Techniques Employed in CE

6. COMPETITIVE LANDSCAPE

  • Biopharmaceutical Bioseparations Market - A Highly Consolidated Market
    • Table 18: Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2017): Percentage Market Share Breakdown of Revenues for 3M, GE Healthcare, Merck, Pall Corp, Sartorius and Others (includes corresponding Graph/Chart)
  • Liquid Chromatography Market
    • Table 19: Leading Players in Global Liquid Chromatography Market (2017): Percentage Breakdown of Value Sales for Agilent Technologies, Shimadzu, Thermo Fisher Scientific, Waters, and Others (includes corresponding Graph/Chart)
  • High Level of Fragmentation Typifies Electrophoresis Competitive Landscape
  • Competitive Scenario in the Global Flow Cytometry Market
  • 6.1 Focus on Select Players
  • 3M (USA)
  • AB Sciex LLC (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Laval AB (Sweden)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Flottweg SE (Germany)
  • Fluidigm Corporation (USA)
  • GE Healthcare (USA)
  • Groupe Novasep (France)
  • Hitachi High-Technologies Corp. (Japan)
  • Illumina, Inc. (USA)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • PerkinElmer, Inc. (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Repligen Corporation (USA)
  • Sartorius Stedim Biotech SA (France)
  • SEPMAG (Spain)
  • Shimadzu Scientific Instruments (USA)
  • Sysmex Partec GmbH (Germany)
  • Thermo Fisher Scientific, Inc. (USA)
  • 6.2 Product Innovations/Introductions
  • Novasep Launches BioSC(r) Pilot
  • Merck Launches New CellStream(tm) Benchtop Flow Cytometry System
  • 6.3 Recent Industry Activity
  • Bio-Techne Acquires Quad Technologies
  • Quad Technologies Enters into Partnership with Sartorius Stedim Biotech
  • OSAKA SODA to Acquire Chromatography Business of Shiseido China Company
  • Merck Acquires Natrix Separations
  • Repligen Enters into Merger with Spectrum
  • Thermo Fisher Scientific Snaps Up Affymetrix
  • Repligen Takes Over Atoll

7. GLOBAL MARKET PERSPECTIVE

    • Table 20: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 22: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Type - DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Commercial Biotechnology Separation Systems by Type - DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for Commercial Biotechnology Separation Systems by Type - Percentage Breakdown of Revenues for DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray and Others Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

  • 8.1 The United States
  • A. Market Analysis
    • Current & Future Analysis
    • United States: The Largest Biopharmaceutical Market Globally
    • Table 26: Number of Biologics Approved by the Center for Biologics Evaluation and Research (CBER): 2007-2017 (includes corresponding Graph/Chart)
      • Biosimilar Approvals in the US (as of H1 2018)
      • Pipeline Biosimilar Products in the US (as of H1 2018)
    • Impending Patent Expiries Signal Growth Prospects
    • Table 27: Leading Biopharmaceuticals by Developer, Therapeutic Area, Expiration Date and Revenue (in US$ Billion) for 2017 (includes corresponding Graph/Chart)
    • Select Trends in Biopharmaceutical Market
      • Manufacturers Shift Focus to Small Bioreactors
      • Biosimilar Drug Developers Face Higher Litigation Risks
    • US Flow Cytometry Market - An Overview
    • Table 28: US Flow Cytometry Market (2018): Percentage Breakdown of Sales by End-Use Industry - Clinical, Industrial and Research (includes corresponding Graph/Chart)
    • Growth in Protein Electrophoresis Segment to Persist
      • Factors Influencing Purchasing Decisions in Protein Electrophoresis Equipment Market
      • Major Factors Influencing Purchasing Decision for Protein Electrophoresis
      • Key Trends in the US PE Market
      • Ready-Made Gels Grow at the Expense of Hand-Cast Gels
  • B. Market Analytics
    • Table 29: US Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: US Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.2 Canada
  • A. Market Analysis
    • Current & Future Analysis
    • Canada - A Lucrative Biopharmaceutical Industry
  • B. Market Analytics
    • Table 31: Canadian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 32: Canadian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.3 Japan
  • Market Analysis
    • Table 33: Japanese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 34: Japanese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • 8.4 Europe
  • A. Market Analysis
    • Current & Future Analysis
    • European Biopharmaceutical Industry - Select Trends
      • Funding Challenges Faced by Biopharmaceutical Startups
      • Healthcare Agencies Looking to Embrace Biosimilars to Cut Healthcare Costs
    • Slew of Product Approvals Scale Up Market Revenues
      • Biosimilar Approvals in Europe (as of H1 2018)
  • B. Market Analytics
    • Table 35: European Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 36: European Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 37: European 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.4.1 France
  • Market Analysis
    • Table 38: French Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: French Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.4.2 Germany
  • Market Analysis
    • Table 40: German Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 41: German Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • 8.4.3 Italy
  • Market Analysis
    • Table 42: Italian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: Italian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.4.4 The United Kingdom
  • Market Analysis
    • Table 44: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: UK Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.4.5 Spain
  • Market Analysis
    • Table 46: Spanish Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 47: Spanish Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.4.6 Russia
  • A. Market Analysis
    • Current & Future Analysis
    • Russia Sets Eyes on Emerging as a Notable Pharmaceutical Industry
    • Encouragement for Local Manufacturing to Drive Demand
    • Challenges - Need for Extensive R&D
  • B. Market Analytics
    • Table 48: Russian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 49: Russian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • 8.4.7 Rest of Europe
  • Market Analysis
    • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.5 Asia-Pacific
  • A. Market Analysis
    • Current & Future Analysis
    • Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
  • B. Market Analytics
    • Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 53: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 54: Asia-Pacific 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.5.1 China
  • Market Analysis
    • Table 55: Chinese Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 56: Chinese Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
  • 8.5.2 India
  • A. Market Analysis
    • Current & Future Analysis
    • Favorable End-use Market Dynamics Drive Demand for Flow Cytometers
    • Table 57: Flow Cytometry Market in India (2017): Percentage Breakdown of Sales by End-Use Industry - Clinical Research, Life Sciences and Pharmaceutical (includes corresponding Graph/Chart)
      • Factors Affecting the Market
      • Competitive Landscape in the Indian Flow Cytometry Market
    • Indian Electrophoresis Market - An Overview
      • Key Growth Drivers of The Electrophoresis Market
      • Drug Production Requirements Boost Growth
      • Competitive Landscape
  • B. Market Analytics
    • Table 58: Indian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 59: Indian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.5.3 Rest of Asia-Pacific
  • A. Market Analysis
    • Current & Future Analysis
    • Increasing Number of Biosimilar Approvals Drives Growth for Biotechnology Separation Systems
      • Biosimilar Approvals in South Korea (as of H1 2018)
  • B. Market Analytics
    • Table 60: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 61: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.6 Middle East & Africa
  • Market Analysis
    • Table 62: Middle East & African Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 63: Middle East & African Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.7 Latin America
  • Market Analysis
    • Table 64: Latin American Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 65: Latin American Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 66: Latin American 14-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
  • 8.7.1 Brazil
  • Market Analysis
    • Table 67: Brazilian Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 68: Brazilian Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • 8.7.2 Rest of Latin America
  • Market Analysis
    • Table 69: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 70: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

9. COMPANY PROFILES Total Companies Profiled: 46 (including Divisions/Subsidiaries - 51) The United States (27) Canada (1) Japan (4) Europe (16) - France (2) - Germany (8) - The United Kingdom (1) - Spain (2) - Rest of Europe (3) Asia-Pacific (Excluding Japan) (3)

Back to Top
전화 문의
F A Q
 
BCC Research